omeros $68,200,000
IPO
October 2009
vistanote $3,000,000
Private Placement
August 2009
CRS, LLC Asset Sale
June 2009
celanese Private Placement
August 2008
xshares $15,300,000
Private Placement
June 2008
mgt Private Placement
April 2008
generic $7,600,000
Private Placement
March 2008
soundpharma Principal Investment
December 2007

What We Do

Broadmark Capital is an established, boutique merchant bank that provides financing and management services and direct investment to help emerging companies grow and create shareholder value.

Track Record

For 20 years, Broadmark has raised capital, invested and advised on transactions with an aggregate value of well over $1 billion - but our experience runs deeper. Our success reflects a comprehensive understanding of the challenges companies face in raising capital and our long-term relationships with investors who trust us to structure mutually advantageous financing opportunities.

Approach

Broadmark's core strength is its intense focus on understanding clients' businesses and shaping financing opportunities to reflect their companies' strengths and the ever-changing priorities of the capital markets. We are deeply involved with our clients' businesses. As a merchant bank, we also invest directly in many of our client companies. That means that every decision we make reflects the shared interests of our firm and yours.

Key Points of Difference

For some banks, your business is just another "deal." When you engage Broadmark, you gain an ally that will support you through every stage of the financing process - and perhaps an investor. When transactions prove unusually challenging, our resourceful team will sit around the conference room table with you and drill down on your project to develop creative strategies to help facilitate a successful round of financing. And Broadmark will continue adding value to your business even after the financing is complete, providing valuable insight and hands-on support as your company continues to grow.

White Papers

The Decline of Washington's Life Sciences Industry: Causes and Solutions - March 1, 2010

The Shortest Path to Recreating Economic Growth in the United States - November 12, 2008 (revised March 13, 2009)